APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lumateperone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lumateperone Industry Growth and Trends Forecast to 2032

29 December 202572 pages

Choose your research edition.

Industry ResearchLumateperone Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Lumateperone Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Lumateperone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lumateperone Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Lumateperone Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Lumateperone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lumateperone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lumateperone include Intra‑Cellular Therapies. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lumateperone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lumateperone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lumateperone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lumateperone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lumateperone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lumateperone Market by Company

Intra‑Cellular Therapies

Lumateperone Segment by Type

Capsules

Injectable

Lumateperone Segment by Application

Schizophrenia

Depression

Other

Lumateperone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lumateperone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lumateperone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lumateperone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lumateperone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lumateperone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Injectable Table 3. Global Lumateperone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lumateperone Sales by Type (2021-2026) & (K Units) Table 5. Global Lumateperone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lumateperone Sales Market Share in Value by Type (2021-2026) Table 8. Global Lumateperone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Lumateperone Sales by Type (2027-2032) & (K Units) Table 10. Global Lumateperone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lumateperone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lumateperone Sales Market Share in Value by Type (2027-2032) Table 13. Global Lumateperone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Lumateperone Sales by Type (2021-2026) & (K Units) Table 15. North America Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lumateperone Sales by Type (2021-2026) & (K Units) Table 17. Europe Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lumateperone Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lumateperone Sales by Type (2021-2026) & (K Units) Table 21. Latin America Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lumateperone Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Lumateperone Sales by Type (2021-2026) & (US$ Million) Table 24. Lumateperone Industry Trends Table 25. Lumateperone Industry Drivers Table 26. Lumateperone Industry Opportunities and Challenges Table 27. Lumateperone Industry Restraints Table 28. Global Lumateperone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lumateperone Revenue Market Share by Company (2021-2026) Table 30. Global Lumateperone Sales by Company (2021-2026) & (K Units) Table 31. Global Lumateperone Sales Share by Company (2021-2026) Table 32. Global Lumateperone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Lumateperone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lumateperone Major Company Production Sites and Headquarters Table 35. Global Lumateperone Company, Product Type & Application Table 36. Global Lumateperone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lumateperone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lumateperone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lumateperone Sales by Region (2021-2026) & (K Units) Table 41. Global Lumateperone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lumateperone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lumateperone Sales Market Share in Value by Region (2021-2026) Table 44. Global Lumateperone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Lumateperone Sales by Region (2027-2032) & (K Units) Table 46. Global Lumateperone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lumateperone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lumateperone Sales Market Share in Value by Region (2027-2032) Table 49. Global Lumateperone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Lumateperone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lumateperone Sales by Application (2021-2026) & (K Units) Table 52. Global Lumateperone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lumateperone Sales Market Share in Value by Application (2021-2026) Table 55. Global Lumateperone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Lumateperone Sales by Application (2027-2032) & (K Units) Table 57. Global Lumateperone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lumateperone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lumateperone Sales Market Share in Value by Application (2027-2032) Table 60. Global Lumateperone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Lumateperone Sales by Application (2021-2026) & (K Units) Table 62. North America Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lumateperone Sales by Application (2021-2026) & (K Units) Table 64. Europe Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lumateperone Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lumateperone Sales by Application (2021-2026) & (K Units) Table 68. Latin America Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lumateperone Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Lumateperone Sales by Application (2021-2026) & (US$ Million) Table 71. Intra‑Cellular Therapies Company Information Table 72. Intra‑Cellular Therapies Business Overview Table 73. Intra‑Cellular Therapies Lumateperone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Intra‑Cellular Therapies Lumateperone Product Portfolio Table 75. Intra‑Cellular Therapies Recent Development Table 76. North America Lumateperone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 77. North America Lumateperone Sales by Country (2021-2026) & (K Units) Table 78. North America Lumateperone Sales Market Share by Country (2021-2026) Table 79. North America Lumateperone Sales Forecast by Country (2027-2032) & (K Units) Table 80. North America Lumateperone Sales Market Share Forecast by Country (2027-2032) Table 81. North America Lumateperone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Lumateperone Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Lumateperone Market Share by Country (2021-2026) Table 84. North America Lumateperone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Lumateperone Market Share Forecast by Country (2027-2032) Table 86. Europe Lumateperone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. Europe Lumateperone Sales by Country (2021-2026) & (K Units) Table 88. Europe Lumateperone Sales Market Share by Country (2021-2026) Table 89. Europe Lumateperone Sales Forecast by Country (2027-2032) & (K Units) Table 90. Europe Lumateperone Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Lumateperone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Lumateperone Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Lumateperone Market Share by Country (2021-2026) Table 94. Europe Lumateperone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Lumateperone Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Lumateperone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Lumateperone Sales by Country (2021-2026) & (K Units) Table 98. Asia-Pacific Lumateperone Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Lumateperone Sales Forecast by Country (2027-2032) & (K Units) Table 100. Asia-Pacific Lumateperone Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Lumateperone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Lumateperone Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Lumateperone Market Share by Country (2021-2026) Table 104. Asia-Pacific Lumateperone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Lumateperone Market Share Forecast by Country (2027-2032) Table 106. Latin America Lumateperone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Latin America Lumateperone Sales by Country (2021-2026) & (K Units) Table 108. Latin America Lumateperone Sales Market Share by Country (2021-2026) Table 109. Latin America Lumateperone Sales Forecast by Country (2027-2032) & (K Units) Table 110. Latin America Lumateperone Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Lumateperone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Lumateperone Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Lumateperone Market Share by Country (2021-2026) Table 114. Latin America Lumateperone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Lumateperone Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Lumateperone Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Lumateperone Sales by Country (2021-2026) & (K Units) Table 118. Middle East and Africa Lumateperone Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Lumateperone Sales Forecast by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Lumateperone Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Lumateperone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Lumateperone Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Lumateperone Market Share by Country (2021-2026) Table 124. Middle East and Africa Lumateperone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Lumateperone Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Lumateperone Distributors List Table 129. Lumateperone Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Lumateperone Image Figure 2. Global Lumateperone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lumateperone Market Size (2021-2032) & (US$ Million) Figure 4. Global Lumateperone Sales (2021-2032) & (K Units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injectable Image Figure 8. Global Injectable Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Lumateperone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lumateperone Market Share by Type 2025 VS 2032 Figure 11. North America Lumateperone Sales Market Share in Volume by Type in 2025 Figure 12. North America Lumateperone Sales Market Share in Value by Type in 2025 Figure 13. Europe Lumateperone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lumateperone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lumateperone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lumateperone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lumateperone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lumateperone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lumateperone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lumateperone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lumateperone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Schizophrenia Image Figure 24. Global Schizophrenia Sales YoY Growth (2021-2032) & (K Units) Figure 25. Depression Image Figure 26. Global Depression Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Lumateperone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lumateperone Market Share by Application 2025 VS 2032 Figure 31. North America Lumateperone Sales Market Share in Volume by Application in 2025 Figure 32. North America Lumateperone Sales Market Share in Value by Application in 2025 Figure 33. Europe Lumateperone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lumateperone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lumateperone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lumateperone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lumateperone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lumateperone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lumateperone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lumateperone Sales Market Share in Value by Application in 2025 Figure 41. North America Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Lumateperone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lumateperone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lumateperone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Lumateperone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lumateperone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lumateperone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Lumateperone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lumateperone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lumateperone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Lumateperone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lumateperone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lumateperone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lumateperone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Lumateperone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lumateperone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lumateperone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lumateperone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lumateperone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Injectable
Applications
  • Schizophrenia
  • Depression
  • Other
Companies covered
  • Intra‑Cellular Therapies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lumateperone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lumateperone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lumateperone Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Injectable
  8. 1.4 Global Lumateperone Market Size by Type
  9. 1.4.1 Global Lumateperone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lumateperone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lumateperone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lumateperone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lumateperone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lumateperone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lumateperone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lumateperone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lumateperone Industry Trends
  2. 2.2 Lumateperone Industry Drivers
  3. 2.3 Lumateperone Industry Opportunities and Challenges
  4. 2.4 Lumateperone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lumateperone Revenue (2021-2026)
  2. 3.2 Global Top Players by Lumateperone Sales (2021-2026)
  3. 3.3 Global Top Players by Lumateperone Price (2021-2026)
  4. 3.4 Global Lumateperone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lumateperone Major Company Production Sites & Headquarters
  6. 3.6 Global Lumateperone Company, Product Type & Application
  7. 3.7 Global Lumateperone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lumateperone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lumateperone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lumateperone Tier 1, Tier 2, and Tier 3
4 Lumateperone Regional Status and Outlook
  1. 4.1 Global Lumateperone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lumateperone Historic Market Size by Region
  3. 4.2.1 Global Lumateperone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lumateperone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lumateperone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lumateperone Forecasted Market Size by Region
  7. 4.3.1 Global Lumateperone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lumateperone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lumateperone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lumateperone by Application
  1. 5.1 Lumateperone Market by Application
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Depression
  4. 5.1.3 Other
  5. 5.2 Global Lumateperone Market Size by Application
  6. 5.2.1 Global Lumateperone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lumateperone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lumateperone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lumateperone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lumateperone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lumateperone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lumateperone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lumateperone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Intra‑Cellular Therapies
  2. 6.1.1 Intra‑Cellular Therapies Company Information
  3. 6.1.2 Intra‑Cellular Therapies Business Overview
  4. 6.1.3 Intra‑Cellular Therapies Lumateperone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Intra‑Cellular Therapies Lumateperone Product Portfolio
  6. 6.1.5 Intra‑Cellular Therapies Recent Developments
7 North America by Country
  1. 7.1 North America Lumateperone Sales by Country
  2. 7.1.1 North America Lumateperone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lumateperone Sales by Country (2021-2026)
  4. 7.1.3 North America Lumateperone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lumateperone Market Size by Country
  6. 7.2.1 North America Lumateperone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lumateperone Market Size by Country (2021-2026)
  8. 7.2.3 North America Lumateperone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lumateperone Sales by Country
  2. 8.1.1 Europe Lumateperone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lumateperone Sales by Country (2021-2026)
  4. 8.1.3 Europe Lumateperone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lumateperone Market Size by Country
  6. 8.2.1 Europe Lumateperone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lumateperone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lumateperone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lumateperone Sales by Country
  2. 9.1.1 Asia-Pacific Lumateperone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lumateperone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lumateperone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lumateperone Market Size by Country
  6. 9.2.1 Asia-Pacific Lumateperone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lumateperone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lumateperone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lumateperone Sales by Country
  2. 10.1.1 South America Lumateperone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lumateperone Sales by Country (2021-2026)
  4. 10.1.3 South America Lumateperone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lumateperone Market Size by Country
  6. 10.2.1 South America Lumateperone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lumateperone Market Size by Country (2021-2026)
  8. 10.2.3 South America Lumateperone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lumateperone Sales by Country
  2. 11.1.1 Middle East and Africa Lumateperone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lumateperone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lumateperone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lumateperone Market Size by Country
  6. 11.2.1 Middle East and Africa Lumateperone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lumateperone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lumateperone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lumateperone Value Chain Analysis
  2. 12.1.1 Lumateperone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lumateperone Production Mode & Process
  7. 12.2 Lumateperone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lumateperone Distributors
  10. 12.2.3 Lumateperone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst